术中神经监测市场规模、份额、成长分析、按产品和服务、按来源类型、按应用、按模式、按最终用户、按地区 - 行业预测，2024-2031 年

2022 年，术中神经监测的全球市场规模为 31.2 亿美元，从 2023 年的 32.7 亿美元成长到 2031 年的 47.6 亿美元，预计在预测期内（2024-2031 年）将成长。成长率为4.8%。

由于术中神经监测在手术期间即时监测和评估神经系统方面发挥的关键作用，预计 2022 年至 2030 年全球术中神经监测市场的复合年增长率将达到 4.9%。这项创新技术对于有效评估神经系统的完整性和功能至关重要，特别是在可能损害大脑、脊髓和周围神经的高风险手术中。术中神经监测包括各种技术，例如肌电图、脑电图和诱发电位。在患者安全意识增强和技术进步的推动下，市场预计将成长。此外，中风、癫痫、阿兹海默症和帕金森氏症等慢性神经系统疾病的发生率不断上升，进一步增加了对神经监测解决方案的需求。世界卫生组织 (WHO) 透露，全球每年约有 1500 万人经历中风，凸显了全球需要更强大的监测设备。术中神经监测市场也预计将保持稳健的成长轨迹，这反映出美国日益重视复杂外科手术中的病患安全，以及神经监测在改善手术结果和增强病患整体体验方面的重要性。技术创新、意识提高和神经系统疾病流行等累积因素可能在未来几年推动术中神经监测市场强劲发展。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价格分析
• 价值链分析
• 市场生态系统
• 贸易分析
• 供应链分析
• 案例研究分析
• 专利分析
• 客户和购买标准分析
• 监管环境
• 创新矩阵
• 主要投资分析
• 关键成功因素
• 竞争程度

术中神经监测市场：依产品及服务分类

• 市场概况
• 系统
• 配件
• 服务

术中神经监测市场：依来源类型

• 市场概况
• 内部监控
• 外部监测

术中神经监测市场：依应用分类

• 市场概况
• 脊椎手术
• 神经外科
• 整形外科手术
• 耳鼻喉科手术
• 血管外科
• 其他手术

术中神经监测市场：依方式分类

• 市场概况
• 运动诱发电位 (MEP)
• 体感诱发电位 (SSEP)
• 脑电图（EEG）
• 肌电图（EMG）
• 脑干听觉诱发电位 (BAEP)
• 视觉诱发电位（VEP）

术中神经监测市场：依最终使用者分类

• 市场概况
• 医院
• 日间手术中心 (ASC)

按地区分類的术中神经监测市场规模

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Natus Medical Incorporated（US）
• Accurate Monitoring（US）
• Neuromonitoring Technologies（US）
• Medtronic（Ireland）
• NuVasive, Inc.（US）
• SpecialtyCare（US）
• Cadwell Industries, Inc.（US）
• Alpha Omega Engineering, Inc.（US）
• Biotronic NeuroNetwork（US）
• IntraOp Medical Corporation（US）
• NeuroWave Systems, Inc.（US）
• Integra LifeSciences Corporation（US）
• Zynex, Inc.（US）
• Medtronic（Ireland）
• Stryker Corporation（US）
• Nerve Monitoring Services, Inc.（US）
• Neurodiagnostic Services（US）
• Aesculap, Inc.（US）
• Elekta AB（Sweden）
• OrLive（US）
• Stimwave Technologies（US）

Global Intraoperative Neuromonitoring Market size was valued at USD 3.12 billion in 2022 and is poised to grow from USD 3.27 billion in 2023 to USD 4.76 billion by 2031, growing at a CAGR of 4.8% during the forecast period (2024-2031).

The global intraoperative neuromonitoring market is projected to experience a compound annual growth rate (CAGR) of 4.9% from 2022 to 2030, driven by its critical role in real-time monitoring and assessment of the nervous system during surgeries. This innovative technique is essential for the effective evaluation of the integrity and function of the nervous system, particularly in high-risk operations that may jeopardize the brain, spinal cord, and peripheral nerves. Intraoperative neuromonitoring encompasses various techniques, including electromyography, electroencephalography, and evoked potentials. The market is poised for growth, fueled by increasing awareness of patient safety and advancements in technology. Additionally, the rising incidence of chronic neurological disorders, such as stroke, epilepsy, Alzheimer's, and Parkinson's disease, further underscores the demand for neuromonitoring solutions. The World Health Organization highlights that approximately 15 million people worldwide experience a cerebral stroke annually, highlighting the global need for enhanced monitoring devices. In the United States, the intraoperative neuromonitoring market is also expected to sustain a robust growth trajectory, reflecting a growing emphasis on patient safety during complex surgical procedures, underscoring the importance of neuromonitoring in improving surgical outcomes and enhancing the overall patient experience. The cumulative factors of technological innovation, heightened awareness, and the prevalence of neurological disorders are set to firmly propel the intraoperative neuromonitoring market forward in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intraoperative Neuromonitoring market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intraoperative Neuromonitoring Market Segmental Analysis

Global Intraoperative Neuromonitoring Market is segmented by Products and Services, Source Type, Application, Modality, End User, and region. Based on Products and Services, the market is segmented into Systems, Accessories, and Services. Based on Source Type, the market is segmented into Insourced Monitoring, and Outsourced Monitoring. Based on Application, the market is segmented into Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery, and Other surgeries. Based on Modality, the market is segmented into Motor evoked potentials (MEPs), Somatosensory evoked potentials (SSEPs), Electroencephalography (EEG), Electromyography (EMG), Brainstem auditory evoked potentials (BAEPs), and Visual evoked potentials (VEPs). Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Intraoperative Neuromonitoring Market

The global intraoperative neuromonitoring market is experiencing robust growth driven by the increasing aging population, which is more vulnerable to chronic illnesses like heart disease, diabetes, and neurological disorders. As healthcare providers aim to enhance surgical outcomes and patient safety, advanced neurosurgery devices and less invasive surgical technologies are becoming essential. Innovations such as the NIM Vital system provide real-time nerve status information, optimizing surgical strategies and improving patient quality of life. Furthermore, the rising trend of medical tourism and escalating healthcare investments in developing regions present lucrative opportunities, while chronic health challenges driven by modern lifestyles further stimulate demand for neuromonitoring solutions.

Restraints in the Global Intraoperative Neuromonitoring Market

The Global Intraoperative Neuromonitoring (IONM) market faces significant restraints primarily due to the high costs associated with IONM devices and procedures. Prices for EEG devices range from US$ 1,000 to over US$ 25,000, creating budget challenges for healthcare facilities, leading many to opt for refurbished devices rather than investing in new technology. Additionally, a shortage of trained professionals to manage and maintain these advanced monitoring systems further hampers market growth. Compounding these issues is the lack of awareness regarding the benefits of IONM, especially in developing economies, which restricts adoption and ultimately limits market expansion.

Market Trends of the Global Intraoperative Neuromonitoring Market

The Global Intraoperative Neuromonitoring (IONM) market is experiencing a significant upward trend post-pandemic, fueled by a resurgence in elective surgeries and heightened awareness of IONM's benefits to patient safety and surgical outcomes. Technological advancements in IONM equipment are further driving this market, offering improved accuracy and ease of use, which enhances the affordability and accessibility of these services. As healthcare providers increasingly incorporate IONM into surgical protocols, the market is poised for robust growth, reflecting a collective shift towards enhanced patient monitoring and safety during surgical procedures worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Intraoperative Neuromonitoring Market by Products and Services

• Market Overview
• Systems
• Accessories
• Services

Intraoperative Neuromonitoring Market by Source Type

• Market Overview
• Insourced Monitoring
• Outsourced Monitoring

Intraoperative Neuromonitoring Market by Application

• Market Overview
• Spinal Surgery
• Neurosurgery
• Orthopedic Surgery
• ENT Surgery
• Vascular Surgery
• Other surgeries

Intraoperative Neuromonitoring Market by Modality

• Market Overview
• Motor evoked potentials (MEPs)
• Somatosensory evoked potentials (SSEPs)
• Electroencephalography (EEG)
• Electromyography (EMG)
• Brainstem auditory evoked potentials (BAEPs)
• Visual evoked potentials (VEPs)

Intraoperative Neuromonitoring Market by End User

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)

Intraoperative Neuromonitoring Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Natus Medical Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accurate Monitoring (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuromonitoring Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuVasive, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SpecialtyCare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadwell Industries, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alpha Omega Engineering, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronic NeuroNetwork (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IntraOp Medical Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroWave Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zynex, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nerve Monitoring Services, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neurodiagnostic Services (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesculap, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrLive (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments